DLL1 and Sepsis: Therefore, we measured DLL1 in plasma samples of prospective cohorts with sepsis, signs of infection in the emergency department, bacterial skin infection with Staphylococcus aureus, Hidradenitis Suppurativa, and inflammatory bowel disease [10,11,12,13,14,15].